BLESELDA PARAGAS: Open Payments
NPI 1437348265 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,863 in 90 payments from 16 companies in 2025. Trend: 2023 $1,996 · 2024 $1,709 · 2025 $1,863
Food & beverage: $1,580Education: $283
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $380 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $331 |
| E.R. Squibb & Sons, L.L.C. | 13 | $177 |
| ABBVIE INC. | 9 | $154 |
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| Lilly USA, LLC | 6 | $131 |
| PFIZER INC. | 6 | $124 |
| GENZYME CORPORATION | 3 | $72 |
| Arcutis Biotherapeutics, Inc. | 2 | $65 |
| Incyte Corporation | 3 | $63 |
Products named: TREMFYA, Sotyktu, ILUMYA, CIBINQO, COSENTYX, TALTZ, RINVOQ, SKYRIZI.
Industry payments across NV — which companies pay providers there.
